Vivani Medical Inc. (VANI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $91.11M
Last updated: Nov 17, 2026 at 4:16 PM ET
Vivani Medical Inc. (VANI) Statistics
Vivani Medical (VANI) has a market cap of $91.11M and an enterprise value of $76.51M. Its share count is up 50.93% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 16.02% below the market cap, as cash exceeds debt.
| Market Cap | $91.11M |
|---|---|
| Enterprise Value | $76.51M |
| Latest price (Nov 17, 2026) | $1.05 |
Key Dates
The next earnings report is expected on Mar 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 11, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 26.06% over 52 weeks and trades 10.26% below its 50-day average.
| Beta (1Y) | 1.27 |
|---|---|
| 52-Week Change | -26.06% |
| 1-Month Change | -6.25% |
| 3-Month Change | -24.46% |
| 6-Month Change | -8.70% |
| 5-Year Change | -86.74% |
| 10-Year Change | -98.26% |
| Total Return (1Y) | -26.06% |
| Total Return (5Y CAGR) | -31.63% |
| Return vs SPY (1Y) | -37.09% |
| Max Drawdown (1Y) | -38.54% |
| Max Drawdown (3Y) | -77.77% |
| Sharpe Ratio (1Y) | -0.48 |
| Correlation with SPY (1Y) | 0.28 |
| 50-Day Average | $1.17 |
| 200-Day Average | $1.24 |
| 52-Week Range | $0.80 to $1.66 |
| RSI (14 Days) | 42.9 |
| Average Volume (20 Days) | 284.46K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.40x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 2.40x |
|---|---|
| Quick Ratio | 2.40x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -204.52% and return on assets is -76.56% over the last 12 months.
| Return on Equity (ROE) | -204.52% |
|---|---|
| Return on Assets (ROA) | -76.56% |
| ROA (5Y Average) | -88.29% |
Scores
VANI has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$115.00K |
| Operating Income | -$28.04M |
| Pretax Income | -$26.58M |
| Net Income | -$27.03M |
| Reported EPS (TTM) | -$0.32 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 37.44% of the $35.31M in total assets.
| Cash and Equivalents | $14.59M |
|---|---|
| Total Debt | $0 |
| Net Cash | $14.59M |
| Net Cash Per Share | $0.16 |
| Working Capital | $9.25M |
| Shareholder Equity | $13.22M |
| Book Value Per Share | $0.15 |
| Total Assets | $35.31M |
| Total Liabilities | $22.09M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$25.34M |
|---|---|
| FCF Per Share | -$0.29 |
| Depreciation and Amortization | $502.00K |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | -21.28% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -21.28% |
Dividends and Yields
VANI does not pay a dividend.
| Buyback Yield | -39.59% |
|---|---|
| Shareholder Yield | -39.59% |
Stock Splits
The last split was a 1-for-3 reverse split on Aug 19, 2022.
| Last Split Date | Aug 19, 2022 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:3 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About VANI
What is VANI's market cap?
Vivani Medical has a market cap of $91.11M. Its enterprise value, which adds debt and subtracts cash, is $76.51M.
How many shares of VANI are outstanding?
Vivani Medical has 90.12M shares outstanding. The count is up 50.93% from a year earlier.
Does VANI pay a dividend?
No. Vivani Medical does not pay a dividend.
How much debt does VANI have?
Vivani Medical has $0 of total debt and $14.59M of cash and equivalents, a net cash position of $14.59M.
VANI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors